P. Hindryckx

Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study

Silvio Danese, Jean‐Frédéric Colombel, Milan Lukáš et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 93 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +14

Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial

Laurent Peyrin‐Biroulet, Ailsa Hart, Peter Bossuyt et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 93 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +15

Immune-mediated pathology following hepatitis B vaccination. Two cases of polyarteritis nodosa and one case of pityriasis rosea-like drug eruption.

Filip De Keyser, Jean Naeyaert, P. Hindryckx et al. · PubMed · 2000 · 51 citations

Medicine, Dermatology, Pathology +14

Belgian recommendations for the management of anemia in patients with inflammatory bowel disease.

P. Hindryckx, Leila Amininejad, Els Van de Vijver et al. · PubMed · 2014 · 12 citations · Full text

Medicine, Hematology, Internal Medicine +13